Damora Therapeutics, Inc. Ordinary Shares DMRA
$24.53
-0.89%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-10 | View → |
| 8-K | 8-K | 2026-07-20 | View → |
| 4 | 4 | 2026-07-07 | View → |
| 8-K | 8-K | 2026-06-17 | View → |
| 10-Q | 10-Q | 2026-05-12 | View → |
| 8-K | 8-K | 2026-05-04 | View → |
| DEF 14A | DEF 14A | 2026-04-29 | View → |
| 8-K | 8-K | 2026-04-20 | View → |
| 4 | 4 | 2026-04-01 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 4 | 4 | 2026-03-25 | View → |
| 8-K | 8-K | 2026-03-23 | View → |
| 10-K | 10-K | 2026-03-19 | View → |
| 8-K | 8-K | 2026-03-10 | View → |
| 4 | 4 | 2026-02-12 | View → |
| 4 | 4 | 2026-02-12 | View → |
| 8-K | 8-K | 2026-02-11 | View → |
| 424B5 | 424B5 | 2026-02-11 | View → |
| 424B5 | 424B5 | 2026-02-10 | View → |
| 8-K | 8-K | 2026-02-10 | View → |
| 4 | 4 | 2026-01-26 | View → |
| 8-K | 8-K | 2026-01-12 | View → |
| 4 | 4 | 2026-01-07 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 4 | 4 | 2026-01-06 | View → |
| 8-K | 8-K | 2026-01-06 | View → |
| DEF 14A | DEF 14A | 2025-12-31 | View → |
| S-3 | S-3 | 2025-12-16 | View → |
| 8-K | 8-K | 2025-11-10 | View → |
| 10-Q | 10-Q | 2025-11-06 | View → |
| 10-Q | 10-Q | 2025-08-05 | View → |
| 4 | 4 | 2025-07-08 | View → |
| 4 | 4 | 2025-07-08 | View → |
| 4 | 4 | 2025-07-08 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $24.53
- Market Cap
- $1.51 billion
- 52-Week Range
- $16.50 – $34.89
- Average Volume
- 437K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.